Tissue RepairModerate Evidence

Pentosan Polysulfate

Also known as: PPS, Elmiron

Semi-synthetic sugar-based compound (not strictly a peptide). Taken by mouth as Elmiron, it is FDA-approved for bladder pain from interstitial cystitis; it has also been studied for osteoarthritis.

Evidence

Moderate

FDA status

FDA-approved

Source

Semi-synthetic derivative from beechwood hemicellulose

Overview

Semi-synthetic sugar-based compound (not strictly a peptide). Taken by mouth as Elmiron, it is FDA-approved for bladder pain from interstitial cystitis; it has also been studied for osteoarthritis.

Mechanism of Action

Stimulates proteoglycan synthesis and incorporation into cartilage ECM, inhibits MMP-3 and other degradative enzymes, enhances TIMP-3 levels, reduces inflammatory cytokines (IL-1, TNF-α), improves subchondral bone blood flow, exhibits mild antithrombotic and fibrinolytic activity.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Cartilage breakdown in lab and animal studies
  • Cartilage matrix production in lab studies
  • Reduces joint inflammation
  • Improves synovial fluid quality
  • Enhances joint nutrition and microcirculation
  • Pain and stiffness in small osteoarthritis trials

Researched for

Includes FDA-approved uses where marked; other items are research topics, not approved uses.

Osteoarthritis (knee, hip, other joints)Interstitial cystitisDegenerative joint diseasePost-traumatic arthritisCartilage injuries

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Pentosan Polysulfate isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Multiple preclinical studies, clinical trials in equine and human OA

Summary

FDA-approved (oral Elmiron) for interstitial cystitis. Osteoarthritis use is off-label; small trials report some benefit, and larger trials are needed. Long-term oral use is linked to a pigment change in the retina, so FDA added a warning to the label.

Safety Information

Potential Side Effects

  • •Injection site pain
  • •Mild bleeding risk
  • •Gastrointestinal upset
  • •Hair loss (rare)
  • •Retinal pigmentary changes (long-term oral use)

Contraindications

  • Bleeding disorders
  • Active gastric ulcers
  • Severe hepatic or renal impairment

Interactions

  • ⚠Anticoagulants (increased bleeding risk)
  • ⚠Aspirin and NSAIDs

Quick Facts

CategoryTissue Repair
SourceSemi-synthetic derivative from beechwood hemicellulose
StatusFDA-approved by mouth (Elmiron) for interstitial cystitis; osteoarthritis use is off-label